These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35974938)

  • 1. Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: A double blind randomized clinical trial.
    Daneshyar S; Ghiasian M; Moradi S; Khanlarzadeh E
    Caspian J Intern Med; 2022; 13(3):617-622. PubMed ID: 35974938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
    Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options in juvenile myoclonic epilepsy.
    Mantoan L; Walker M
    Curr Treat Options Neurol; 2011 Aug; 13(4):355-70. PubMed ID: 21494841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA; García VF; Astencio AG; Cuartas VB
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A; Velizarova R; Genton P; Gélisse P
    Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Baftiu A; Syvertsen M; Enger U; Koht J; Johannessen SI
    Epilepsy Res; 2019 Sep; 155():106148. PubMed ID: 31195184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road.
    Baheti N; Rathore C; Bansal AR; Shah S; Veedu HK; Prakash S; Kanhere K; Jaiswal SK; Jukkarwala A; Murthy JMK; Radhakrishnan K
    Seizure; 2021 Nov; 92():112-117. PubMed ID: 34496330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy.
    Auvin S
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):729-34. PubMed ID: 19300607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy.
    Silvennoinen K; de Lange N; Zagaglia S; Balestrini S; Androsova G; Wassenaar M; Auce P; Avbersek A; Becker F; Berghuis B; Campbell E; Coppola A; Francis B; Wolking S; Cavalleri GL; Craig J; Delanty N; Johnson MR; Koeleman BPC; Kunz WS; Lerche H; Marson AG; O'Brien TJ; Sander JW; Sills GJ; Striano P; Zara F; van der Palen J; Krause R; Depondt C; Sisodiya SM;
    Epilepsia Open; 2019 Sep; 4(3):420-430. PubMed ID: 31440723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.
    Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Catania C; Ferlazzo E; Pascarella A; Casciato S; Quarato P; Pizzanelli C; Pulitano P; Giuliano L; Viola V; Mostacci B; Fortunato F; Marini C; Di Gennaro G; Gambardella A; Labate A; Operto FF; Giallonardo AT; Baykan B; Beier CP; Di Bonaventura C;
    JAMA Neurol; 2023 Nov; 80(11):1174-1181. PubMed ID: 37782485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
    Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
    Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pediatric epilepsy: expert opinion, 2005.
    Wheless JW; Clarke DF; Carpenter D
    J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of juvenile myoclonic epilepsy.
    Auvin S
    CNS Neurosci Ther; 2008; 14(3):227-33. PubMed ID: 18684236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lamotrigine monotherapy in patients with newly diagnosed juvenile myoclonic epilepsy: An open-label study.
    Schimschock JR; Hammer AE; Kustra RP; Messenheimer JA
    Curr Ther Res Clin Exp; 2005 May; 66(3):230-7. PubMed ID: 24672126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.